Disrupt PAD III
ClinicalTrials.gov NCT02923193
Research payments
$136,450
Through program year 2023, $136,450 in research payments was reported against Disrupt PAD III, across 62 payments, paid by Shockwave Medical, Inc.
- Paid by
- Shockwave Medical, Inc
- ClinicalTrials.gov
- NCT02923193
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $32,820 | 17 |
| 2022 | Research | $103,630 | 45 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- William Miller Fort Collins, CO Named on 5 payments
- Carlos Mena-Hurtado New Haven, CT Named on 4 payments
- Sahil Parikh New York, NY Named on 3 payments
- Sean Janzer York, PA Named on 3 payments
- Sarang Mangalmurti Bryn Mawr, PA Named on 3 payments
- William Bachinsky Harrisburg, PA Named on 3 payments
- Patrick Alexander Southfield, MI Named on 3 payments
- Barry Bertolet Tupelo, MS Named on 3 payments
- Lawrence Garcia Brighton, MA Named on 2 payments
- Nicolas Shammas Davenport, IA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.